Skip to main content
Top
Published in: Acta Diabetologica 1/2020

01-01-2020 | Type 2 Diabetes | Original Article

Prediction of 5-year risk of diabetes mellitus in relatively low risk middle-aged and elderly adults

Authors: Hua Hu, Jing Wang, Xu Han, Yaru Li, Xiaoping Miao, Jing Yuan, Handong Yang, Meian He

Published in: Acta Diabetologica | Issue 1/2020

Login to get access

Abstract

Aims

To determine the potential risk factors and construct the predictive model of diabetic risk among a relatively low risk middle-aged and elderly Chinese population.

Methods

Information of participants was collected in the Dongfeng-Tongji cohort study, a perspective cohort study of Chinese occupational population. The main outcome was incident type 2 diabetes (T2DM). Based on the conventional risk factors of diabetes, we defined low risk participants without underlying diseases such as coronary heart disease, stroke, cancer, dyslipidemia, hypertension, metabolic syndrome, obesity and family history of diabetes. Totally, 4833 participants from the Dongfeng-Tongji cohort study were enrolled, and of them, 171 had an incident diagnosis of T2DM during 4.6 years of follow-up period. A Cox proportional hazards model was used to estimate effects of risk factors. The restricted cubic spline regression and the Youden index were used to explore the optimal cutoffs of risk factors, and the C index was used to assess the discrimination power of prediction models.

Results

There were significant linear relationships between BMI/TG level/fasting glucose level and incident diabetic risk among low risk participants. In the restricted cubic spline regression, when fasting glucose level was above 5.4 mmol/L, TG above 1.06 mmol/L and BMI above 22 kg/m2, the HRs (95% CIs) of diabetes were above 1.0. The detailed HRs (95% CI) were 1.29 (1.01, 1.64), 2.57 (1.00, 6.58), and 1.49 (1.00, 2.22), respectively. The optimal cutoff determined by the Yonden index was 1.1 mmol/L for TG, 24 kg/m2 for BMI and 5.89 mmol/L for fasting plasma glucose, respectively. The C index was 0.75 (95% CI: 0.7–0.81) when age, sex, smoke status, physical activity, BMI (< 24 kg/m2 and ≥ 24 kg/m2), TG (< 1.1 mmol/L and ≥ 1.1 mmol/L), and FPG (< 5.89 mmol/L and ≥ 5.89 mmol/L) were introduced into the diabetes predictive model.

Conclusions

Fasting plasma glucose level, BMI, and triglyceride level were still dominated factors to predict 5-year diabetic risk among the relatively low risk participants. The cutoff values for fasting plasma glucose, TG, and BMI set as 5.89 mmol/L, 1.1 mmol/L, and 24 kg/m2, respectively, had the best predictive discrimination of diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference International Diabetes Federation (2017) IDF diabetes atlas, 8th edn. International Diabetes Federation, Brussel, Belgium International Diabetes Federation (2017) IDF diabetes atlas, 8th edn. International Diabetes Federation, Brussel, Belgium
2.
go back to reference Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880CrossRef Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 338:b880CrossRef
3.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes. Diabetes Care 24(5):1047–1053CrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes. Diabetes Care 24(5):1047–1053CrossRef
4.
go back to reference Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes/Metab Res Rev 16(3):164–171CrossRef Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes/Metab Res Rev 16(3):164–171CrossRef
5.
go back to reference Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26(3):725–731CrossRef Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26(3):725–731CrossRef
6.
go back to reference Gray LJ, Taub NA, Khunti K et al (2010) The leicester risk assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27(8):887–895CrossRef Gray LJ, Taub NA, Khunti K et al (2010) The leicester risk assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med 27(8):887–895CrossRef
7.
go back to reference Wilson PWF (2007) Prediction of incident diabetes mellitus in middle-aged adults. Arch Intern Med 167(10):1068CrossRef Wilson PWF (2007) Prediction of incident diabetes mellitus in middle-aged adults. Arch Intern Med 167(10):1068CrossRef
8.
go back to reference Beshara A, Cohen E, Goldberg E, Lilos P, Garty M, Krause I (2016) Triglyceride levels and risk of type 2 diabetes mellitus: a longitudinal large study. J Investig Med 64(2):383–387CrossRef Beshara A, Cohen E, Goldberg E, Lilos P, Garty M, Krause I (2016) Triglyceride levels and risk of type 2 diabetes mellitus: a longitudinal large study. J Investig Med 64(2):383–387CrossRef
9.
go back to reference Tirosh A, Shai I, Tekes-Manova D et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. New England J Med 353(14):1454–1462CrossRef Tirosh A, Shai I, Tekes-Manova D et al (2005) Normal fasting plasma glucose levels and type 2 diabetes in young men. New England J Med 353(14):1454–1462CrossRef
10.
go back to reference Odegaard AO, Koh WP, Vazquez G et al (2009) BMI and diabetes risk in Singaporean Chinese. Diabetes Care 32(6):1104–1106CrossRef Odegaard AO, Koh WP, Vazquez G et al (2009) BMI and diabetes risk in Singaporean Chinese. Diabetes Care 32(6):1104–1106CrossRef
11.
go back to reference Wang F, Zhu J, Yao P et al (2013) Cohort profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol 42(3):731–740CrossRef Wang F, Zhu J, Yao P et al (2013) Cohort profile: the Dongfeng-Tongji cohort study of retired workers. Int J Epidemiol 42(3):731–740CrossRef
12.
go back to reference Zhou X, Qiao Q, Ji L et al (2013) Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey. Diabetes Care 36:3944–3952CrossRef Zhou X, Qiao Q, Ji L et al (2013) Nonlaboratory-based risk assessment algorithm for undiagnosed type 2 diabetes developed on a nation-wide diabetes survey. Diabetes Care 36:3944–3952CrossRef
13.
go back to reference Xu Y, Wang L, He J et al (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959CrossRef Xu Y, Wang L, He J et al (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959CrossRef
14.
go back to reference Daviglus ML, Pirzada A, Durazo-Arvizu R et al (2016) Prevalence of low cardiovascular risk profile among diverse hispanic/latino adults in the united states by age, sex, and level of acculturation: the hispanic community health study/study of latinos. J Am Heart Assoc 5(8):e003929CrossRef Daviglus ML, Pirzada A, Durazo-Arvizu R et al (2016) Prevalence of low cardiovascular risk profile among diverse hispanic/latino adults in the united states by age, sex, and level of acculturation: the hispanic community health study/study of latinos. J Am Heart Assoc 5(8):e003929CrossRef
15.
go back to reference Sun D, Li F, Zhang Y, Xu X (2014) Associations of the pre-pregnancy BMI and gestational BMI gain with pregnancy outcomes in Chinese women with gestational diabetes mellitus. Int J Clin Exp Med 7(12):5784–5789PubMedPubMedCentral Sun D, Li F, Zhang Y, Xu X (2014) Associations of the pre-pregnancy BMI and gestational BMI gain with pregnancy outcomes in Chinese women with gestational diabetes mellitus. Int J Clin Exp Med 7(12):5784–5789PubMedPubMedCentral
16.
go back to reference Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645CrossRef Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645CrossRef
17.
go back to reference Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statist Med 23:2109–2123CrossRef Pencina MJ, D’Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Statist Med 23:2109–2123CrossRef
18.
go back to reference Qiu G, Zheng Y, Wang H et al (2016) Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults. Int J Epidemiol 45(5):1507–1516CrossRef Qiu G, Zheng Y, Wang H et al (2016) Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults. Int J Epidemiol 45(5):1507–1516CrossRef
19.
go back to reference Hara K, Fujita H, Johnson TA et al (2014) Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet 23(1):239–246CrossRef Hara K, Fujita H, Johnson TA et al (2014) Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet 23(1):239–246CrossRef
20.
go back to reference Gray BJ, Bracken RM, Turner D et al (2015) Different type 2 diabetes risk assessments predict dissimilar numbers at ‘high risk’: a retrospective analysis of diabetes risk-assessment tools. Br J Gen Pract 65(641):e852–860CrossRef Gray BJ, Bracken RM, Turner D et al (2015) Different type 2 diabetes risk assessments predict dissimilar numbers at ‘high risk’: a retrospective analysis of diabetes risk-assessment tools. Br J Gen Pract 65(641):e852–860CrossRef
21.
go back to reference Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK (2015) Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA 313(10):1029–1036CrossRef Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK (2015) Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA 313(10):1029–1036CrossRef
22.
go back to reference Wang B, Zhang M, Liu Y et al (2018) Utility of three novel insulin resistance-related lipid indices for predicting type 2 diabetes mellitus among people with normal fasting glucose in rural China. J Diabetes 10(8):641–652CrossRef Wang B, Zhang M, Liu Y et al (2018) Utility of three novel insulin resistance-related lipid indices for predicting type 2 diabetes mellitus among people with normal fasting glucose in rural China. J Diabetes 10(8):641–652CrossRef
23.
go back to reference Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 57(2–4):91–97CrossRef Capurso C, Capurso A (2012) From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol 57(2–4):91–97CrossRef
24.
go back to reference Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46(1):3–10CrossRef Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46(1):3–10CrossRef
25.
go back to reference Trauner M, Arrese M, Wagner M (2010) Fatty liver and lipotoxicity. Biochim Biophys Acta 1801(3):299–310CrossRef Trauner M, Arrese M, Wagner M (2010) Fatty liver and lipotoxicity. Biochim Biophys Acta 1801(3):299–310CrossRef
26.
go back to reference Dotevall A, Johansson S, Wilhelmsen L, Rosengren A (2004) Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women: a prospective 18-year follow-up of the BEDA study. Diabetic Med 21(6):615–622CrossRef Dotevall A, Johansson S, Wilhelmsen L, Rosengren A (2004) Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women: a prospective 18-year follow-up of the BEDA study. Diabetic Med 21(6):615–622CrossRef
27.
go back to reference Russo GT, De Cosmo S, Viazzi F, Pacilli A, Ceriello A, Genovese S (2016) Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care 39(12):2278–2287CrossRef Russo GT, De Cosmo S, Viazzi F, Pacilli A, Ceriello A, Genovese S (2016) Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care 39(12):2278–2287CrossRef
28.
go back to reference Federation ID (2008) Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. The Lancet 371(9607):117–125CrossRef Federation ID (2008) Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis. The Lancet 371(9607):117–125CrossRef
29.
go back to reference Drew BG, Duffy SJ, Formosa MF et al (2009) High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 119(15):2103–2111CrossRef Drew BG, Duffy SJ, Formosa MF et al (2009) High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation 119(15):2103–2111CrossRef
30.
go back to reference Sone H, Tanaka S, Tanaka S et al (2011) Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab 96(11):3448–3456CrossRef Sone H, Tanaka S, Tanaka S et al (2011) Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS). J Clin Endocrinol Metab 96(11):3448–3456CrossRef
31.
go back to reference Bragg F, Tang K, Guo Y et al (2018) Associations of general and central adiposity with incident diabetes in chinese men and women. Diabetes Care 41(3):494–502CrossRef Bragg F, Tang K, Guo Y et al (2018) Associations of general and central adiposity with incident diabetes in chinese men and women. Diabetes Care 41(3):494–502CrossRef
32.
go back to reference Dale CE, Fatemifar G, Palmer TM et al (2017) Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a mendelian randomization analysis. Circulation 135(24):2373–2388CrossRef Dale CE, Fatemifar G, Palmer TM et al (2017) Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a mendelian randomization analysis. Circulation 135(24):2373–2388CrossRef
33.
go back to reference Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359(21):2208–2219CrossRef Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359(21):2208–2219CrossRef
34.
go back to reference Lam TK, Pocai A, Gutierrez-Juarez R et al (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11(3):320–327CrossRef Lam TK, Pocai A, Gutierrez-Juarez R et al (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11(3):320–327CrossRef
35.
go back to reference Razak F, Anand SS, Shannon H et al (2007) Defining obesity cut points in a multiethnic population. Circulation 115(16):2111–2118CrossRef Razak F, Anand SS, Shannon H et al (2007) Defining obesity cut points in a multiethnic population. Circulation 115(16):2111–2118CrossRef
36.
go back to reference Association AD (2017) Classification and diagnosis of diabetes. Diabetes Care 40(Supplement 1):S11–S24CrossRef Association AD (2017) Classification and diagnosis of diabetes. Diabetes Care 40(Supplement 1):S11–S24CrossRef
37.
go back to reference Pich´e M (2004) What is a normal glucose value? Diabetes Care 27(10):2470–2477CrossRef Pich´e M (2004) What is a normal glucose value? Diabetes Care 27(10):2470–2477CrossRef
38.
go back to reference Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44(8):929–945CrossRef Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44(8):929–945CrossRef
Metadata
Title
Prediction of 5-year risk of diabetes mellitus in relatively low risk middle-aged and elderly adults
Authors
Hua Hu
Jing Wang
Xu Han
Yaru Li
Xiaoping Miao
Jing Yuan
Handong Yang
Meian He
Publication date
01-01-2020
Publisher
Springer Milan
Keyword
Type 2 Diabetes
Published in
Acta Diabetologica / Issue 1/2020
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-019-01375-w

Other articles of this Issue 1/2020

Acta Diabetologica 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.